While negotiations are underway for PVA Type Da items, 22 items are said to have undergone correction due to increased usage due to Corona 19 last year. The NHIS plans to finalize the negotiations by this month, including these items, and report the results of the negotiations to the Health Insurance Policy Deliberation Committee of the Ministry of Health and Welfare next month. According to the industry on the 17th, the government is negotiating by correcting the number of drugs that have increased usage due to Corona 19 last year and selecting a target for negotiation.

Items subject to PVA Type Da are drugs that have not been negotiated at the time of initial registration, and if the billing amount in